"FDA, HHS, the Federal Trade Commission (FTC), and Department of Justice will increase oversight and enforcement under current authorities for violations of direct-to-consumer (DTC) prescription drug advertising laws. Egregious violations demonstrating harm from current practices will be prioritized, including by social media influencers and DTC telehealth companies (including dissemination of risk information and quality of life through misleading and deceptive advertising on social media and digital platforms)."
"This contradicts what he told a NewsNation Town Hall on June 28, 2023 (1:01:25): "We don't have a priesthood here. We don't have high priests who are telling us ... we're in charge of our own lives. Americans need to do their own research, and you know, listen, people say 'trust the experts.' That became a mantra during COVID...." Apparently, Secretary Kennedy doesn't want to let Americans do "their own research" when it comes to learning about new drugs. He only wants the high priests to have that information."
On September 9 the MAHA Commission outlined a strategy prioritizing stricter oversight of direct-to-consumer (DTC) prescription drug advertising. FDA, HHS, the FTC, and the Department of Justice will increase enforcement under existing authorities, targeting egregious violations that demonstrate harm. Enforcement priorities include misleading and deceptive advertising by social media influencers and DTC telehealth companies, especially regarding dissemination of risk information and quality-of-life claims on digital platforms. Robert F. Kennedy Jr. has opposed DTC advertising and previously called for a ban, yet he has also said Americans should do their own research. The strategy stops short of an outright ban, citing legal constraints such as Supreme Court precedent.
#direct-to-consumer-advertising #drug-regulation #fda--ftc-enforcement #social-media-health-misinformation
Read at Cato Institute
Unable to calculate read time
Collection
[
|
...
]